To ask the Secretary of State for Health and Social Care, what steps he is taking to improve allergy care.

The Expert Advisory Group on Allergy (EAGA), co-chaired by the Department and the National Allergy Strategy Group, meets regularly to bring together stakeholders across the Government, the National Health Service, voluntary organisations, professional bodies, and patient representative groups, to consider how allergy care and support could be improved. The purpose of the EAGA is to inform policymaking, and to identify priorities in relation to the holistic care of people with allergies. The EAGA last met on 3 December2025.

In July 2025, the Medicines and Healthcare products regulatory Agency licensed a new adrenaline nasal spray, EURneffy, for use in the emergency treatment of anaphylaxis. The Government welcomes the approval of needle free delivery methods of adrenaline, recognising the potential to benefit to those who suffer from allergies.

More widely, there are a number of policies outlined in the 10-Year Health Plan which should have a positive impact on care for patients with allergy. More tests and scans delivered in the community, better joint working between services, and greater use of technology will all support people to manage allergies closer to home.

Neighbourhood Health Services will be organised around the needs of their patients. The plan will create joined-up working across hospitals and into community settings with multi-disciplinary teams who can provide wrap-around support services to people with allergies or other long-term conditions.